高警訊藥品管理 1. 管制措施 (1) 醫令上設定 : i) 藥品設限連結相關診斷碼始得開立 ii) 建檔藥名前端加註 @ iii) 醫令線上處方集外觀 (2) 藥局調劑台及藥局庫存區 : i) 需與其他藥品區隔, 獨立空間置放 ii) 藥品藥名標示貼紙標籤以醒目紅色為標籤底色 (3) 處方箋及藥袋 : i) 藥品品名前端及藥袋上之藥名後面加註 @, 以茲提醒 ii) 藥袋上標示藥品外觀說明 中文藥名 iii) 發藥時適時確認是否知道使用注意事項及衛教 2. 高警訊藥品品項 一 Adrenergic agonists, IV - 注射時需監測心電圖和血壓 IDOBUT Dobutamine Dobutamine IDOPA2 Dopamine Dopamine IDOPA4 Dopamine Easydopa IEPHE4 Ephedrine Ephedrine IBOSM Epinephrine Bosmin ILEVOP Norepinephrine Levophed 二 Adrenergic antagonists, IV ITRAND Labetalol Trandate IESMOL Esmolol Esmolol 三 Anesthetic agents, general, inhaled and IV - 須注意過量引起 之心臟呼吸系統抑制 IMARC2 Bupivacaine Marcaine IMARCA Bupivacaine Marcaine spinal 0.5% I
IMARC Bupivacaine Marcaine spinal ( 等張 ) IPROPO Propofol Propofol (Diprivan) ICITO Thiamylal Citosol IKET Ketamin Ketalar IDHBP Droperidol Droperidol 四 Antiarrhythmics, IV IADENO Adenosine Adenocor ICORDA Amiodarone Cordarone IXYLO2 Lidocaine Lidocaine 2 % 20 ml / vial IXYLIV Lidocaine Xylocaine 2 % 5ml / amp IHERB5 Diltiazem Herbesser 50mg / amp 五 Antithrombotic agents (anticoagulants)- 密切觀察是否發生 出血的併發症 IENOXA Enoxaparin Clexane IHEPA5 Heparin Heparin IUROK Plasminogen Urokinase activator IRTPA Tissue γ-tpa plasminogen activator IAGGRA Tirofiban Aggrastat OCOUM1 Warfarin Coumadin 1mg OCOUM3 Warfarin Coumadin 3mg OCOUMA Warfarin Coumadin 5mg ORIVAR Rivaroxaban Xaletro 10mg ORIV15 Rivaroxaban Xaletro 15mg OPRADA Dabigatran Pradax 110mg II
六 Chemotherapeutic agents, parenteral and oral 抗腫瘤藥品, 具細胞毒性 I5FU 5-Fluorouracil 5-FU IENDOX Cyclosphamide Endoxan IDOXOR Doxorubicin Lipo-Dox Liposome IEPIR1 Epirubicin Pharmorubicin 10mg IEPIR5 Epirubicin Pharmorubicin 50mg IIRINO Irinotecan Irinotecan ILEUPL Leuprorelin Leuplin Depot IMETHO Methotrexate Methotrexate inj IOXALI Oxaliplatin Oxaliplatin ONOLVA Tamoxifene Nolvadex OUFUR Tegafur + Uracil Ufur ICETUX Cetuximab Erbitux 七 Dextrose, hypertonic, 20% or greater IDEXTB Glucose Dextrose 20% IDEXTC Glucose Dextrose 50% 八 Hypoglycemics,oral 降血糖藥品, 易引起低血糖症狀 OACARB Acarbose Glucobay OEUGLU Glibenclamide Euglucon OGLUM5 Glibenclamide/ Glucomet ODIAMI Gliclazide Mezide OGLIME Glimepiride Grumed OAMARM Glimepiride/ Amaryl M OMINID Glipizide Minidiab OMETFO Glibudon ONOVON Repaglinide Novonorm III
OACTOS Pioglitazone Actos OACTOM Pioglitazone/ Actosmet OSITAG Sitagliptin Januvia OJANUM Sitagliptin/ Janumet OVILDA Vidagliptin Galvus OGALM5 Vidagliptin/ Galvus Met OSAXAG Saxagliptin Onglyza OLINAG Linagliptin Trajenta ILIRAG Liraglutide Victoza 九 Inotropic medications, IV 應監測血壓 心跳速率, 不當使用易引起立即致命危險 ODIGOX Digoxin Digoxin oral IDIGOX Digoxin Digoxin inj 十 insulin, subcutaneous and IV 注意低血糖症狀 IINSUN Humulin N (NPH) NPH IINSUR Humulin R (RI) RI IMIX30 30% insulin aspart Novo-mix + 70% insulin aspart protamine INOVOR insulin aspart Novorapid IDETEM Insulin Detemir Levemir Flex IHUMAP 25% Insulin lispro + 75% Insulin lispro protamine Humalog mix25 kwikpen IV
十一 Moderate sedation agents, IV IVALIU Diazepam Valium INEURO Lorazepam Neuropam IDORMI Midazolam Dormicum 十二 Moderate sedation agents, oral, for children OCHLOA Chloral hydrate Chloral hydrate OLUMIN Phenobarbital Luminal 十三 Narcotics/opiates, IV, transdermal, and oral - 長期使用易造成生理依賴性 IFENTA Fentanyl Fentanyl inj IFEN10 Fentanyl Fentanyl inj EFENT2 Fentanyl Durogesic TTS25μg/h EFENT5 Fentanyl Durogesic TTS50μg/h IDEMER Meperidine Demerol inj. OMORPH Morphine Morphine oral IMORPH Morphine Morphine inj. ICODEI Codeine Codeine inj. 十四 Neuromuscular blocking agents 神經肌肉阻斷劑 - 必須有足夠設備以供氣管內管及人工呼吸器之應用 ITRAC Atracurium Tracrium IPAVUL Pancuronium Pavulon ISUCCI Succinylcholine Relaxin 十五 Parenteral nutrition preparations ITPN2A TPN 二合一 Nutriflex V
十六 Sodium chloride for injection, hypertonic, greater than 0.9% concentration I3SOCH Sodium chloride 3% Normal saline 十七 Specific Medications Magnesium sulfate injection IMAGS Magnesium Sulfate MgSO 4 Methotrexate, oral, non-oncologic use OMTX Methotrexate Methotrexate Oxytocin, IV IPITON Oxytocin Piton-S 高濃度輸液, 不可直接 IV PUSH Potassium chloride for injection concentrate IKCL Potassium Chloride KCL Potassium phosphates injection IPOTPH potassium phosphate Potassium phosphate Vasopressin, IV or intraosseous IPITRE Vasopressin Pitressin Reference 1. Cohen MR, ed. Medication errors. Washington, DC. High Alert Medications. American Pharmaceutical Association; 1999. 2. Institute for safe medication practices. ISMP Medication safety. http://www.ismp.org. at 2014.5. VI